Geller Gail, Tambor Ellen S, Bernhardt Barbara A, Fraser Gertrude, Wissow Lawrence S
Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
J Adolesc Health. 2003 Apr;32(4):260-71. doi: 10.1016/s1054-139x(02)00459-7.
To better understand the process by which families at increased risk of disease would decide to enroll their children in genetic susceptibility research in order to develop recommendations regarding the informed consent process by which at-risk children are enrolled in such research in the future [corrected].
Parents and children (ages 10-17 years) from families at increased risk for heart disease (n = 21 dyads) or breast cancer (n = 16 dyads) participated in two face-to-face, audio-taped, semi-structured interviews: Initial interviews were conducted with parents and children separately, and follow-up family interviews were conducted 1 year later. Interview transcripts were coded based on common themes.
Families vary in the stage at which, and degree to which, children would be involved in decision-making about research participation. In general, the older/more mature the child, the less risky the research and the more open the communication style, the greater the likelihood that decisions would be made jointly. Most children wanted some parental input, but still thought the final decision should be theirs. Most parents would want to make the initial decision about whether it would be reasonable to consider enrolling their child in the research being proposed, but none opposed the child having some time alone with the researcher. All parents and children in our study placed extreme importance on not forcing children to participate in nontherapeutic research if they do not want to.
Decision-making about enrolling children in genetic susceptibility research should be based on an informed consent process that (a) gives parents and children sufficient opportunity to ask questions of the researcher(s) and to communicate with one another, and (b) gives children the opportunity to exercise their right to refuse participation without parental influence. This process should be tailored to the child's maturity level and style of communication in the family.
为了更好地理解疾病风险增加的家庭决定让其子女参与遗传易感性研究的过程,以便就未来让高危儿童参与此类研究的知情同意过程制定建议[已修正]。
来自心脏病风险增加家庭(n = 21对)或乳腺癌风险增加家庭(n = 16对)的父母和子女(10 - 17岁)参加了两次面对面、录音的半结构化访谈:初始访谈分别与父母和子女进行,一年后进行后续家庭访谈。访谈记录根据共同主题进行编码。
家庭在子女参与研究参与决策的阶段和程度上存在差异。一般来说,孩子年龄越大/越成熟,研究风险越低,沟通方式越开放,共同做出决策的可能性就越大。大多数孩子希望父母提供一些意见,但仍认为最终决定权应在自己手中。大多数父母希望对是否考虑让孩子参与所提议的研究做出初步决定,但没有人反对孩子与研究人员单独相处一段时间。我们研究中的所有父母和孩子都极其重视不强迫孩子参与他们不想参与的非治疗性研究。
关于让孩子参与遗传易感性研究的决策应基于知情同意过程,该过程(a)给予父母和孩子足够的机会向研究人员提问并相互沟通,(b)给予孩子在不受父母影响的情况下行使拒绝参与权利的机会。这个过程应根据孩子的成熟程度和家庭沟通方式进行调整。